rs1303389437
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP2PP4PS4_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_00138 c.188A>G is a missense variant in FBN1 predicted to cause a substitution of a tyrosine by cysteine at amino acid 63 (p.Tyr63Cys). This variant was found in a proband with a clinical diagnosis of Marfan syndrome (PMID 17657824) (PP4). This variant in FBN1 has been reported three times in ClinVar: 1 time as uncertain significance, 1 time as likely pathogenic, and 1 time as pathogenic (Variation ID: 547296). This variant has previously been reported in at least two apparently unrelated individuals with ectopia lentis (PMID 25053872, 28941062) and in an individual with a suspected or confimed diagnosis of Marfan syndrome (Centre for Human Genetics, Inc. ClinVar entry) (PS4_mod). This variant has been identified in 1/112420 (0.0004%) individuals of European non-Finnish origin (https://gnomad.broadinstitute.org/version 2.1.1). Computational prediction tools and conservation analysis are inconclusive data with regards to a possible impact on this variant protein function and structure (REVEL: 0.72). The constraint z-score for missense variants affecting FBN1 is 5.06 (PP2). Due to the conflicting evidence, this variant is classified as uncertain significance for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PS4_Mod, PP2, PP4 LINK:https://erepo.genome.network/evrepo/ui/classification/CA392448489/MONDO:0007947/022
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Marfan syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- Acromicric dysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- progeroid and marfanoid aspect-lipodystrophy syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- stiff skin syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Weill-Marchesani syndrome 2, dominantInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- geleophysic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated ectopia lentisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal Marfan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Weill-Marchesani syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ectopia lentis 1, isolated, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: G2P
- Shprintzen-Goldberg syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBN1 | NM_000138.5 | c.188A>G | p.Tyr63Cys | missense_variant | Exon 3 of 66 | ENST00000316623.10 | NP_000129.3 | |
| FBN1 | NM_001406716.1 | c.188A>G | p.Tyr63Cys | missense_variant | Exon 2 of 65 | NP_001393645.1 | ||
| FBN1 | NM_001406717.1 | c.188A>G | p.Tyr63Cys | missense_variant | Exon 3 of 9 | NP_001393646.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FBN1 | ENST00000316623.10 | c.188A>G | p.Tyr63Cys | missense_variant | Exon 3 of 66 | 1 | NM_000138.5 | ENSP00000325527.5 | ||
| FBN1 | ENST00000559133.6 | n.188A>G | non_coding_transcript_exon_variant | Exon 3 of 67 | 1 | ENSP00000453958.2 | ||||
| FBN1 | ENST00000537463.6 | n.188A>G | non_coding_transcript_exon_variant | Exon 3 of 31 | 5 | ENSP00000440294.2 | ||||
| FBN1 | ENST00000674301.2 | n.188A>G | non_coding_transcript_exon_variant | Exon 3 of 68 | ENSP00000501333.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249416 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:1Uncertain:1
- -
The NM_00138 c.188A>G is a missense variant in FBN1 predicted to cause a substitution of a tyrosine by cysteine at amino acid 63 (p.Tyr63Cys). This variant was found in a proband with a clinical diagnosis of Marfan syndrome (PMID 17657824) (PP4). This variant in FBN1 has been reported three times in ClinVar: 1 time as uncertain significance, 1 time as likely pathogenic, and 1 time as pathogenic (Variation ID: 547296). This variant has previously been reported in at least two apparently unrelated individuals with ectopia lentis (PMID 25053872, 28941062) and in an individual with a suspected or confimed diagnosis of Marfan syndrome (Centre for Human Genetics, Inc. ClinVar entry) (PS4_mod). This variant has been identified in 1/112420 (0.0004%) individuals of European non-Finnish origin (https://gnomad.broadinstitute.org/version 2.1.1). Computational prediction tools and conservation analysis are inconclusive data with regards to a possible impact on this variant protein function and structure (REVEL: 0.72). The constraint z-score for missense variants affecting FBN1 is 5.06 (PP2). Due to the conflicting evidence, this variant is classified as uncertain significance for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PS4_Mod, PP2, PP4 -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FBN1 protein function. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 547296). This missense change has been observed in individuals with FBN1-related conditions (PMID: 17657824, 25053872, 28941062). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 63 of the FBN1 protein (p.Tyr63Cys). -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); Does not affect a cysteine residue within a calcium-binding EGF-like domain or a TGF-binding protein domain of the FBN1 gene; cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with FBN1-related disorders (PMID: 12938084); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28941062, 25053872, 17657824, 20564469, 12938084) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at